Evidence map›Paper›PMID 30687325›Full record

ArticleFrontiers in immunology2018

Diego Mota Lopes, Sérgio Costa Oliveira, Brady Page, Lucas P Carvalho, Edgar M Carvalho, Luciana Santos Cardoso

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Tropical medicine and infectious disease · 2023
    Review
  5. Review
  6. Schistosome immunomodulators.PLoS pathogens · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Clinical Use ofFrontiers in immunology · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Diego Mota LopesServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Sérgio Costa OliveiraInstituto Nacional de Ciência e Tecnologia em Doenças Tropicais (DT/CNPq), Brasilia, Brazil.
Brady PageMassachusetts General Hospital, Boston, MA, United States.
Lucas P CarvalhoServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Edgar M CarvalhoServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Luciana Santos CardosoServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil.
Complexo Hospitalar Universitário Professor Edgard Santos · BRInstituto Nacional de Ciência e Tecnologia de Doenças Tropicais · BRMassachusetts General Hospital · USUniversidade Federal da Bahia · BR

Funding

The role of Leishmania braziliensis strain polymorphism on disease outcome and ..P50AI030639 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 1991 to 2023
$9.1M
NIAID NIH HHS P50 AI030639
6 · The paper itself

Abstract

The immune response induced by

Indexed as

AnimalsAntigens, HelminthCells, CulturedCoculture TechniquesCytokinesDendritic CellsDisease SusceptibilityFemaleHumansLeishmaniasis, CutaneousLeukocytes, MononuclearLymphocyte ActivationLymphocytesMalePhenotypeRecombinant ProteinsAntigens, HelminthCytokinesRecombinant Proteinscutaneous leishmaniasisdendritic cellslymphocytesSchistosoma mansoniSm29 antigen

Identifiers

PMID30687325
PMCPMC6333737
OpenAlexW2908696671

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.